Formula Using Routine Biochemical Markers Proved Superior to Forn's and APRI in Predicting Early vs. Late-Stage Liver Disease in the HIV/HCV Co-Infected Host

Authors

Margaret Hoffman-Terry MD, FACP, Lehigh Valley Health NetworkFollow
Joseph L. Yozviak DO, FACP, Lehigh Valley Health NetworkFollow
J Mannino, Lehigh Valley Health Network
Sharon R. Kimmel PhD, MHA, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

7-2007

Published In/Presented At

Hoffman-Terry, M., Yozviak, J., Mannino, J., & Kimmel, S. (2007, July 22-25). Formula using routine biochemical markers proved superior to forn's APRI in predicting early vs. late-staged liver disease in the HIV/HCV co-infected host. Poster presented at: The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention, Sydney, Australia.

Disciplines

Diseases | Hepatology | Infectious Disease | Medical Sciences | Medical Specialties | Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Poster